Published in Br J Pharmacol on July 01, 1985
Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase. Proc Natl Acad Sci U S A (1990) 13.34
A novel tumour promoter, thapsigargin, transiently increases cytoplasmic free Ca2+ without generation of inositol phosphates in NG115-401L neuronal cells. Biochem J (1988) 2.49
Hydrogen sulfide (H2S) metabolism in mitochondria and its regulatory role in energy production. Proc Natl Acad Sci U S A (2012) 1.49
Analysis of the stimulative effect of thapsigargin, a non-TPA-type tumour promoter, on arachidonic acid metabolism in rat peritoneal macrophages. Br J Pharmacol (1988) 1.28
Regulation of Ca2+ signaling with particular focus on mast cells. Crit Rev Immunol (2009) 1.20
Thapsigargin, but not caffeine, blocks the ability of thyrotropin-releasing hormone to release Ca2+ from an intracellular store in GH4C1 pituitary cells. Biochem J (1990) 1.05
Phosphorylation at threonine-654 is not required for negative regulation of the epidermal growth factor receptor by non-phorbol tumor promoters. Proc Natl Acad Sci U S A (1989) 0.94
Targeting thapsigargin towards tumors. Steroids (2014) 0.91
Thapsigargin potentiates histamine-stimulated HCl secretion in gastric parietal cells but does not mimic cholinergic responses. Cell Regul (1991) 0.90
Enhancement by cyclo-oxygenase inhibitors of platelet-activating factor production in thapsigargin-stimulated macrophages. Br J Pharmacol (1995) 0.77
Scalable Synthesis of (-)-Thapsigargin. ACS Cent Sci (2016) 0.76
The SAT protein of porcine parvovirus accelerates viral spreading through irreversible ER stress induction. J Virol (2017) 0.75
Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl (1968) 60.35
A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther (1959) 16.61
Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator. J Cell Biol (1982) 11.87
Biological applications of ionophores. Annu Rev Biochem (1976) 9.81
STUDIES ON THE MECHANISMS OF HYPERSENSITIVITY PHENOMENA. IX. HISTAMINE RELEASE FROM HUMAN LEUKOCYTES BY RAGWEED POLLEN ANTIGEN. J Exp Med (1964) 6.30
Release of histamine from mast cells by vasoactive peptides. Proc Soc Exp Biol Med (1973) 2.38
The effect of alkaline earth cations on the release of histamine from rat peritoneal mast cells treated with compound 48/80 and peptide 401. Br J Pharmacol (1979) 2.35
Effects of dibutyryl-3',5'-cyclic adenosine monophosphage, phosphodiesterase inhibitors and prostaglandin E1 on compound 48-80-induced histamine release from rat peritoneal mast cells in vitro. Biochem Pharmacol (1971) 1.76
Thapsigargine and thapsigargicine, two new histamine liberators from Thapsia garganica L. Acta Pharm Suec (1978) 1.57
Muramyl peptides: immunomodulators, sleep factors, and vitamins. Med Res Rev (1984) 1.40
Isolation and some properties of mast cells from the mesentery of the rat and guinea pig. Agents Actions (1980) 1.28
Differential reactivity of isolated mast cells from the rat and guinea pig. Eur J Pharmacol (1980) 1.20
On the mechanism of histamine release induced by thapsigargin from Thapsia garganica L. Agents Actions (1979) 1.12
Palytoxin both induces and inhibits the release of histamine from rat mast cells. Int Arch Allergy Appl Immunol (1982) 0.89
A comparison of histamine secretion from peritoneal mast cells of the rat and hamster. Br J Pharmacol (1984) 0.89
The influence of hypertonicity on histamine release from isolated rat mast cells. Agents Actions (1980) 0.86
Calcium ionophores and movement of calcium ions following the physiological stimulus to a secretory process. Nature (1973) 6.09
Activation of calcium entry by the tumor promoter thapsigargin in parotid acinar cells. Evidence that an intracellular calcium pool and not an inositol phosphate regulates calcium fluxes at the plasma membrane. J Biol Chem (1989) 5.15
Requirement of a downstream sequence for generation of a poly(A) addition site. Cell (1984) 4.87
The role of the alkaline earth ions in anaphylactic histamine secretion. J Physiol (1972) 4.03
The relationship between histamine secretion and 45calcium uptake by mast cells. J Physiol (1977) 3.02
A tool coming of age: thapsigargin as an inhibitor of sarco-endoplasmic reticulum Ca(2+)-ATPases. Trends Pharmacol Sci (1998) 2.92
The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem (1993) 2.66
Mucosal mast cells. I. Isolation and functional characteristics of rat intestinal mast cells. J Immunol (1982) 2.66
Definition of essential sequences and functional equivalence of elements downstream of the adenovirus E2A and the early simian virus 40 polyadenylation sites. Mol Cell Biol (1985) 2.65
Thapsigargin, a novel molecular probe for studying intracellular calcium release and storage. Agents Actions (1989) 2.59
Separation of the glucose-stimulated cytoplasmic and mitochondrial NAD(P)H responses in pancreatic islet beta cells. Proc Natl Acad Sci U S A (2000) 2.50
A novel tumour promoter, thapsigargin, transiently increases cytoplasmic free Ca2+ without generation of inositol phosphates in NG115-401L neuronal cells. Biochem J (1988) 2.49
Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial. Cardiovasc Drugs Ther (1999) 2.48
Effects of MeCh, thapsigargin, and La3+ on plasmalemmal and intracellular Ca2+ transport in lacrimal acinar cells. Am J Physiol (1990) 2.48
Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin. J Physiol (1983) 2.42
The effect of alkaline earth cations on the release of histamine from rat peritoneal mast cells treated with compound 48/80 and peptide 401. Br J Pharmacol (1979) 2.35
Human basophil degranulation is not triggered by very dilute antiserum against human IgE. Nature (1993) 2.34
New perspectives on aflatoxin biosynthesis. Adv Appl Microbiol (1983) 2.33
New anti-HIV-1, antimalarial, and antifungal compounds from Terminalia bellerica. J Nat Prod (1997) 2.22
Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy. Eur Heart J (2000) 2.15
Cromoglycate and other antiallergic drugs: a possible mechanism of action. Br Med J (1976) 2.13
Antileishmanial chalcones: statistical design, synthesis, and three-dimensional quantitative structure-activity relationship analysis. J Med Chem (1998) 2.06
Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization. J Biol Chem (1997) 1.98
The effects of substance P on histamine and 5-hydroxytryptamine release in the rat. J Physiol (1982) 1.88
A possible role for cyclic AMP in the regulation of histamine secretion and the action of cromoglycate. Biochem Pharmacol (1975) 1.80
The calcium mobilizing tumor promoting agent, thapsigargin elevates the platelet cytoplasmic free calcium concentration to a higher steady state level. A possible mechanism of action for the tumor promotion. Biochem Biophys Res Commun (1987) 1.78
Mucosal mast cells. II. Effects of anti-allergic compounds on histamine secretion by isolated intestinal mast cells. J Immunol (1982) 1.77
The antileishmanial activity of novel oxygenated chalcones and their mechanism of action. J Antimicrob Chemother (1999) 1.77
Ca2+ influx in human T lymphocytes is induced independently of inositol phosphate production by mobilization of intracellular Ca2+ stores. A study with the Ca2+ endoplasmic reticulum-ATPase inhibitor thapsigargin. Eur J Immunol (1990) 1.75
Desensitization in the process of histamine secretion induced by antigen and dextran. J Physiol (1974) 1.74
Calcium and histamine secretion from mast cells. Prog Med Chem (1982) 1.70
Ca2+ transients and Mn2+ entry in human neutrophils induced by thapsigargin. Cell Calcium (1989) 1.67
Thapsigargin, a histamine secretagogue, is a non-12-O-tetradecanoylphorbol-13-acetate (TPA) type tumor promoter in two-stage mouse skin carcinogenesis. J Cancer Res Clin Oncol (1986) 1.61
Cross-desensitization of receptors for peptide chemoattractants. Characterization of a new form of leukocyte regulation. J Immunol (1994) 1.60
Effect of thapsigargin on cytoplasmic Ca2+ and proliferation of human lymphocytes in relation to AIDS. Biochim Biophys Acta (1988) 1.59
The inflammatory and tumor-promoting sesquiterpene lactone, thapsigargin, activates platelets by selective mobilization of calcium as shown by protein phosphorylations. Biochim Biophys Acta (1987) 1.58
Characteristics of histamine secretion from rat peritoneal mast cells sensitized to the nematode Nippostrongylus brasiliensis. Immunology (1982) 1.56
Role of intra- and extracellular calcium in histamine release from rat peritoneal mast cells. Agents Actions (1981) 1.53
Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2004) 1.52
Peptides and neurogenic inflammation. Br Med Bull (1987) 1.51
[Leu31, Pro34]neuropeptide Y: a specific Y1 receptor agonist. Proc Natl Acad Sci U S A (1990) 1.50
Bronchoalveolar mast cells in extrinsic asthma: a mechanism for the initiation of antigen specific bronchoconstriction. Br Med J (Clin Res Ed) (1985) 1.49
Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization. J Exp Med (1998) 1.48
Induction of calcium flux across the rat mast cell membrane by bridging IgE receptors. Proc Natl Acad Sci U S A (1979) 1.47
Some studies on the release of histamine from mast cells stimulated with polylysine. Br J Pharmacol (1980) 1.45
Thapsigargin, a new calcium-dependent epithelial anion secretagogue. Br J Pharmacol (1989) 1.41
Induction of histamine secretion by polycations. Biochim Biophys Acta (1980) 1.39
Short- and long-term outcome of balloon angioplasty for compromised side branches after intracoronary stent deployment. Catheter Cardiovasc Interv (1999) 1.39
Fracture of the body of the talus. Acta Orthop Scand (1977) 1.37
Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2. Evidence for time-dependent signal generation. J Biol Chem (1998) 1.36
Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies. Leukemia (2009) 1.35
Mucosal mast cells. III. Effect of quercetin and other flavonoids on antigen-induced histamine secretion from rat intestinal mast cells. J Allergy Clin Immunol (1984) 1.35
Internal Ca2+ mobilization and secretion in bovine adrenal chromaffin cells. Cell Calcium (1989) 1.34
Isolation and properties of cardiac and other mast cells from the rat and guinea-pig. Agents Actions (1985) 1.34
Human mast cells recovered by bronchoalveolar lavage: their morphology, histamine release and the effects of sodium cromoglycate. Clin Sci (Lond) (1985) 1.34
The action of lanthanum and manganese on anaphylactic histamine secretion. Br J Pharmacol (1973) 1.34
The pharmacological control of immediate hypersensitivity. Annu Rev Pharmacol Toxicol (1981) 1.33
Functional heterogeneity of mast cells from different species and tissues. Klin Wochenschr (1982) 1.33
Calcium pools involved in histamine release from rat mast cells. Int Arch Allergy Appl Immunol (1980) 1.30
Nutrition transition in the United Arab Emirates. Eur J Clin Nutr (2011) 1.29
Isolation and some properties of mast cells from the mesentery of the rat and guinea pig. Agents Actions (1980) 1.28
Analysis of the stimulative effect of thapsigargin, a non-TPA-type tumour promoter, on arachidonic acid metabolism in rat peritoneal macrophages. Br J Pharmacol (1988) 1.28
Demonstration of two forms of calcium pumps by thapsigargin inhibition and radioimmunoblotting in platelet membrane vesicles. J Biol Chem (1991) 1.27
Long-term results of Gasserian ganglion electrocoagulation. J Neurosurg (1975) 1.27
Proceedings: Activation of anaphylactic histamine release by calcium and strontium ions. Br J Pharmacol (1972) 1.26
Neural function: metabolism and actions of inositol metabolites in mammalian brain. Philos Trans R Soc Lond B Biol Sci (1988) 1.24
Structure-activity studies: in vitro antileishmanial and antimalarial activities of anthraquinones from Morinda lucida. Planta Med (1999) 1.24
The interaction of calcium and strontium with phosphatidyl serine in the anaphylactic secretion of histamine. J Physiol (1973) 1.23
Excitation wave propagation as a possible mechanism for signal transmission in pancreatic islets of Langerhans. Biophys J (2001) 1.23
Adenosine A3 receptors in mast cells. Trends Pharmacol Sci (1994) 1.21
Movement of strontium ions into mast cells and its relationship to the secretory response. J Physiol (1977) 1.21
Cross-desensitization of chemoattractant receptors occurs at multiple levels. Evidence for a role for inhibition of phospholipase C activity. J Biol Chem (1995) 1.20
Differential reactivity of isolated mast cells from the rat and guinea pig. Eur J Pharmacol (1980) 1.20
Effect of calcium on dextran-induced histamine release from isolated mast cells. Br J Pharmacol (1972) 1.19
Site of action of the antiallergic drugs cromoglycate and doxantrazole [proceedings]. Br J Pharmacol (1977) 1.18
Inhibition of histamine secretion from mast cells. Nature (1981) 1.17
Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinic. Pulm Pharmacol Ther (1999) 1.17
Inhibition of fumarate reductase in Leishmania major and L. donovani by chalcones. Antimicrob Agents Chemother (2001) 1.17
Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection. Antimicrob Agents Chemother (1994) 1.16
Acoustic rhinometry compared with posterior rhinomanometry in the measurement of histamine- and bradykinin-induced changes in nasal airway patency. Br J Clin Pharmacol (1994) 1.15
Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor. J Physiol (1986) 1.15
Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania. Antimicrob Agents Chemother (1993) 1.14
Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor. J Biol Chem (1998) 1.14
Calcium entry in Xenopus oocytes: effects of inositol trisphosphate, thapsigargin and DMSO. Cell Calcium (1993) 1.14
Place of death correlated to sociodemographic factors. A study of 203 patients dying of cancer in a rural Swedish county in 1990. Palliat Med (1996) 1.13
Use of calretinin in the differential diagnosis of unicystic ameloblastomas. Histopathology (2001) 1.13
Effect of cyclic AMP on histamine release induced by compound 48/80. Int Arch Allergy Appl Immunol (1979) 1.13
Influence of cigarette smoking on goiter formation, thyroglobulin, and thyroid hormone levels in women. J Clin Endocrinol Metab (1984) 1.11
Biological activities of phthalocyanines--VIII. Cellular distribution in V-79 Chinese hamster cells and phototoxicity of selectively sulfonated aluminum phthalocyanines. Photochem Photobiol (1988) 1.11
How do inositol phosphates regulate calcium signaling? FASEB J (1989) 1.11
Inositol trisphosphate and thapsigargin discriminate endoplasmic reticulum stores of calcium in rat brain. Biochem Biophys Res Commun (1990) 1.11
Antileishmanial activity of licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovani. Antimicrob Agents Chemother (1994) 1.11
Isolation and study of functional mast cells from lung and mesentery of the guinea pig. Agents Actions (1977) 1.10
The antileishmanial agent licochalcone A interferes with the function of parasite mitochondria. Antimicrob Agents Chemother (1995) 1.10
Myocardial perfusion and function of the systemic right ventricle in patients after atrial switch procedure for complete transposition: long-term follow-up. J Am Coll Cardiol (2000) 1.09